Related Experiment Videos

Interaction between vascular prostheses and rifampicin in the prevention of the grafts infection. An experimental

A Freyrie1, T Curti, M Rodio

  • 1Institute of Vascular Surgery, School of Veterinary, University of Bologna, Italy.

Insights

Rifampicin shows high affinity for Gelseal Dacron prostheses, maintaining antibacterial activity for up to 72 hours in sheep. Knitted Dacron prostheses lost this activity within 24 hours, indicating Gelseal

Area of Science:

  • Vascular Surgery
  • Biomaterials Science
  • Infectious Diseases

Background:

  • Infections associated with synthetic vascular prostheses are a serious complication, occurring in 1.5-6% of cases.
  • Bacterial contamination of prostheses can happen during or immediately after surgery.
  • Rifampicin is an antibiotic with potential for use in preventing prosthesis infections.

Purpose of the Study:

  • To investigate the in vitro and in vivo affinity of Dacron prostheses for Rifampicin.
  • To compare the duration of Rifampicin's antibacterial activity on two types of Dacron prostheses: Gelseal and Knitted.

Main Methods:

  • In vitro study assessing Rifampicin binding to Dacron gel prostheses.
  • In vivo experimental study in sheep implanting Rifampicin-soaked Gelseal and Knitted Dacron prostheses in carotid arteries.
  • Assessment of Rifampicin concentration via Staphylococcus aureus inhibition zones at 2, 24, 48, 72, and 96 hours post-implantation.

Main Results:

  • Gelseal Dacron prostheses demonstrated sustained Rifampicin concentrations with antibacterial activity for up to 72 hours.
  • Knitted Dacron prostheses exhibited antibacterial activity from Rifampicin for only 24 hours.
  • In vitro studies confirmed a strong ionic bond and high affinity between Rifampicin and Dacron gel prostheses.

Conclusions:

  • Gelseal Dacron prostheses exhibit a significantly longer retention of Rifampicin and sustained antibacterial activity compared to Knitted Dacron prostheses.
  • These findings support the potential of using Rifampicin-coated Gelseal Dacron prostheses to reduce infection rates in vascular surgery.

Related Concept Videos